March 26, 2014

Early-stage Alzheimer’s disease, or AD, increasingly is the target of drug development efforts, but there are very few tools that measure the cognitive function of patients with the condition before the onset of dementia. Experts have concluded that it is best to treat patients prior to changes in cognition, before the symptoms of neurodegeneration appear. As a result, scientists have turned to biomarkers to provide some indication of whether AD is likely to develop.

July 8, 2013

More than half of the estimated 5.4 million Americans with Alzheimer's disease and other forms of dementia are at risk of wandering and becoming lost, according to the National Institute on Aging, a figure that has prompted the federal government to develop a series of training videos for police.

April 4, 2013

The annual cost of treating dementia in the United States ranges from $157 billion to $215 billion, according to a new study by the RAND Corp.

April 6, 2012

Sam's Club is offering free screenings for brain health at all of its stores that operate pharmacies this month, the retailer said Friday.

September 21, 2011

A study published in the Sept. 20 issue of Neurology, the medical journal of the American Academy of Neurology, found a link between diabetes and the development of dementia.

November 3, 2010

Nearly 100 drugs are in development for treating Alzheimer’s disease, according to a new report...

July 5, 2010

Generic drug maker Caraco Pharmaceutical Labs has begun shipping a drug for treating dementia, Caraco...

March 7, 2010

Diabetic adults with depression are twice as likely to develop dementia, according to a new...